Science Explorer Back to mapMap
Researcher · Eli Lilly (Germany) · Germany

Peter M. Wehmeier

Peter M. Wehmeier publishes mostly in Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience, on topics such as Schizophrenia research and treatment, Attention Deficit Hyperactivity Disorder and Bipolar Disorder and Treatment.

OpenAlex
World rank
#2,169,693
of 7,710,434 ranked researchers
Rank in Germany
#107,006
of 364,343
Works
46
Citations
2.2k
Citations per work
48.6

What does Peter M. Wehmeier research?

Peter M. Wehmeier's work is mostly in Medicine (35%), Psychology (22%), Neuroscience (7%).

Life Sciences7%Health Sciences39%Social Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1634.6%
    2. Health Professions24.6%
  1. Everything else1531.6%
    1. Psychology1022.3%
    1. Neuroscience36.9%
  1. 1Psychiatry and Mental health35% of their works
  2. 2Clinical Psychology12% of their works
  3. 3Cognitive Neuroscience7% of their works
  4. 4Experimental and Cognitive Psychology6% of their works
  5. 5General Health Professions5% of their works
  6. 6Social Psychology4% of their works

Research topics

Which keywords describe Peter M. Wehmeier's research?

The keywords of their largest research topics: Genetics, Neurobiology, Prevalence, Antipsychotic Drugs, Neurocognitive Deficits, Depression, ADHD and Attention-Deficit/Hyperactivity Disorder.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Genetics253 topics
  2. Neurobiology212 topics
  3. Prevalence212 topics
  4. Antipsychotic Drugs161 topic
  5. Neurocognitive Deficits161 topic
  6. Depression143 topics
  7. ADHD121 topic
  8. Attention-Deficit/Hyperactivity Disorder121 topic
  9. Bipolar Spectrum Disorder91 topic
  10. Treatment Guidelines91 topic
  11. Electroconvulsive Therapy61 topic
  12. Serotonin Syndrome61 topic
  13. Emotion Regulation51 topic
  14. Psychopathology51 topic
  15. Autism Spectrum Disorders41 topic
  16. Neurodevelopmental Disorders41 topic
  17. Phenomenology41 topic
  18. Psychiatric Disorders41 topic
  19. Cytokines31 topic
  20. Neuroinflammation31 topic

Where does Peter M. Wehmeier work?

Peter M. Wehmeier's main affiliation in the publication record is Eli Lilly (Germany), Germany.

How many publications and citations does Peter M. Wehmeier have?

OpenAlex counts 46 works and 2,237 citations for Peter M. Wehmeier, an h-index of 24, ranking #2,169,693 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Peter M. Wehmeier

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Peter M. Wehmeier. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.